自己増幅型RNA合成の世界市場：市場規模・シェア・動向分析 (製品・サービス別、用途別、最終用途別、地域別)、セグメント別予測 (2025年～2030年)

自己増幅型RNA合成市場の成長と動向：

世界の自己増幅型RNA合成の市場規模は、2030年までに3億1,080万米ドルに達すると予測され、2025年から2030年までのCAGRは19.24%で成長すると予測されています。

この拡大は、特にCOVID-19パンデミック時のRNAベースのワクチンや治療薬に対する需要の増加が主な要因です。研究者は、より強力な免疫反応を誘導する能力により、迅速なワクチン開発の有望なプラットフォームとしてsaRNAに注目しています。RNAの自己増幅機能により、投与量を少なくすることができ、副作用も少なくなる可能性があるため、臨床試験での支持が高まっています。その結果、製薬会社は自社の製品パイプラインにsaRNAを組み込むことに注力しており、市場の成長をさらに後押ししています。

個別化医療への関心の高まりも、市場拡大に寄与する重要な要因です。ゲノム技術の進歩に伴い、特定の遺伝子プロファイルをターゲットとしたオーダーメイド治療のニーズが高まっています。自己増幅RNA技術により、個々の患者に合わせたワクチンや遺伝子治療の開発が可能になります。さらに、ヘルスケアシステムがより個別化された治療へとシフトするにつれて、saRNAのような革新的なソリューションに対する需要は高まり続けると思われます。

加えて、感染症の世界の増加と新たな治療オプションの緊急の必要性は、saRNA技術にとって有利な環境を作り出しています。ワクチンだけでなく、自己増幅型RNAは、がん、遺伝性疾患、自己免疫疾患など、さまざまな疾患に対して研究されています。saRNAは様々な用途に合わせて設計できるため、多様な治療オプションが可能となり、官民から多額の投資を集めています。さらに、RNA技術の進歩が進み、臨床試験が増加していることから、市場導入が加速すると予想されます。このような多疾患への応用への関心の高まりは、今後数年間の世界の自己増幅型RNA合成市場の有望な見通しを確実なものにしています。

自己増幅型RNA合成市場：分析概要

• 製品・サービス別では、個別化医薬品やRNAベースの治療薬開発に不可欠なテーラーメイドRNAソリューションに対する需要の高まりから、カスタム合成サービス分野が予測期間中に最も速い成長率を示すと予想されます。
• 用途別では、ワクチンや遺伝子編集ツールなど、RNAベースの治療薬の研究開発の急増がこの分野の成長に大きく寄与したため、治療薬開発分野が市場を独占し、2024年に最大の収益シェアを占めました。
• 最終用途別では、製薬・バイオテクノロジー企業セグメントが2024年に最大の収益シェアを占めました。これらの企業は、RNA治療研究、製品開発、大規模生産を担当しており、RNA合成サービスに対する大きな需要を生み出しています。特にワクチン製造や遺伝子治療のためのRNA技術への多額の投資により、彼らは市場の主要プレーヤーとして位置づけられています。新規ワクチンや遺伝子治療など、開発中のRNAベースの治療法の数が増加していることから、これらの企業はRNA合成ソリューションの主要なエンドユーザーであり続けています。
• 地域別では、北米が自己増幅型RNA合成市場において2024年に最大の売上シェアを占めました。米国は引き続きRNA技術研究をリードしており、RNAベースの治療薬やワクチン開発に多額の投資を行っています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 自己増幅型RNA合成市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 自己増幅型RNA合成市場：分析ツール
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 自己増幅型RNA合成市場：製品・サービス別の推定・動向分析

• 製品・サービス別ダッシュボード
• 世界の自己増幅型RNA合成市場の変動分析：製品・サービス別
• 世界の自己増幅型RNA合成市場：市場規模と動向分析、製品・サービス別（2018～2030年）
• 製品
  • 製品：市場規模の予測と動向分析（2018～2030年）
  • 既製のsaRNA
  • 酵素と試薬
  • その他
• カスタム合成サービス
  • カスタム合成サービス：市場規模の予測と動向分析（2018～2030年）

第5章 自己増幅型RNA合成市場：用途別の推定・動向分析

• 用途別ダッシュボード
• 世界の自己増幅型RNA合成市場の変動分析：用途別
• 世界の自己増幅型RNA合成市場：市場規模と動向分析、用途別（2018～2030年）
• 治療薬開発
  • 治療薬開発：市場規模の予測と動向分析（2018～2030年）
  • 感染症
  • 腫瘍
  • その他
• バイオメディカル研究
  • バイオメディカル研究：市場規模の予測と動向分析（2018～2030年）

第6章 自己増幅型RNA合成市場：最終用途別の推定・動向分析

• 最終用途別ダッシュボード
• 世界の自己増幅型RNA合成市場の変動分析：最終用途別
• 世界の自己増幅型RNA合成市場：市場規模と動向分析、最終用途別（2018～2030年）
• 製薬・バイオテクノロジー企業
  • 製薬・バイオテクノロジー企業：市場規模の予測と動向分析（2018～2030年）
• 学術研究機関
  • 学術研究機関：市場規模の予測と動向分析（2018～2030年）
• その他の最終用途
  • その他の最終用途：市場規模の予測と動向分析（2018～2030年）

第7章 自己増幅型RNA合成市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2024年・2030年）
• 地域別の市場ダッシュボード
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参入企業
• 企業市況分析（2024年）
• 戦略マッピング
• 参入企業の概要
  • ジェンスクリプト
  • クリエイティブバイオジェン
  • OZバイオサイエンス
  • BOCサイエンス
  • クロイエズバイオサイエンス株式会社
  • クリエイティブバイオラボ
  • マラヴァイライフサイエンス
  • アレテルナLLC
  • アプライドDNAサイエンシズ社（LineaRx）

List of Tables

• Table 1 List of abbreviations
• Table 2 North America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 3 North America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 4 North America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 5 North America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 6 U.S. Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 7 U.S. Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 8 U.S. Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 9 Canada Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 10 Canada Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 11 Canada Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 12 Mexico Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 13 Mexico Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 14 Mexico Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 15 Europe Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 16 Europe Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 17 Europe Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 18 Europe Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 UK Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 20 UK Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 21 UK Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 22 Germany Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 23 Germany Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Germany Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Italy Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 26 Italy Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 27 Italy Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 28 France Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 29 France Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 30 France Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 31 Spain Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 32 Spain Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 33 Spain Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 34 Sweden Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 35 Sweden Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 36 Sweden Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 37 Denmark Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 38 Denmark Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 39 Denmark Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 40 Norway Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 41 Norway Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 42 Norway Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 China Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 48 China Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 49 China Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 50 Japan Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 51 Japan Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 52 Japan Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 53 India Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 54 India Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 55 India Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 56 South Korea Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 57 South Korea Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 58 South Korea Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 59 Australia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 60 Australia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 61 Australia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Thailand Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 63 Thailand Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 64 Thailand Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 65 Latin America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 66 Latin America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 67 Latin America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 68 Latin America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Brazil Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 70 Brazil Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 71 Brazil Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 72 Argentina Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 73 Argentina Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 74 Argentina Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 75 Middle East Africa Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 76 Middle East Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 77 Middle East Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 78 Middle East Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 South Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 80 South Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 81 South Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 85 UAE Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 86 UAE Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 87 UAE Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
• Table 88 Kuwait Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 89 Kuwait Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
• Table 90 Kuwait Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value-Chain-Based Sizing & Forecasting
• Fig. 6 QFD Modeling for Market Share Assessment
• Fig. 7 Market formulation & Validation
• Fig. 8 Self-Amplifying RNA Synthesis Market: Market Outlook
• Fig. 9 Parent Market Outlook
• Fig. 10 Related/Ancillary Market Outlook
• Fig. 11 Penetration and Growth Prospect Mapping
• Fig. 12 Industry Value Chain Analysis
• Fig. 13 Self-Amplifying RNA Synthesis Market Driver Impact
• Fig. 14 Self-Amplifying RNA Synthesis Market Restraint Impact
• Fig. 15 Self-Amplifying RNA Synthesis Market Strategic Initiatives Analysis
• Fig. 16 Self-Amplifying RNA Synthesis Market: Product & Service Movement Analysis
• Fig. 17 Self-Amplifying RNA Synthesis Market: Product & Service Outlook and Key Takeaways
• Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 19 Premade saRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 20 Enzymes & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 21 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 22 Custom Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 23 Self-Amplifying RNA Synthesis Market: Application Movement Analysis
• Fig. 24 Self-Amplifying RNA Synthesis Market: Application Outlook and Key Takeaways
• Fig. 25 Therapeutics Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Biomedical Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Self-Amplifying RNA Synthesis Market: End-Use Movement Analysis
• Fig. 31 Self-Amplifying RNA Synthesis Market: End-Use Outlook and Key Takeaways
• Fig. 32 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Other End Use Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Global Self-Amplifying RNA Synthesis Market: Regional Movement Analysis
• Fig. 36 Global Self-Amplifying RNA Synthesis Market: Regional Outlook and Key Takeaways
• Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. Country Dynamics
• Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Canada Country Dynamics
• Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Mexico Country Dynamics
• Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 UK Country Dynamics
• Fig. 46 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Germany Country Dynamics
• Fig. 48 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 France Country Dynamics
• Fig. 50 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Italy Country Dynamics
• Fig. 52 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Spain Country Dynamics
• Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Denmark Country Dynamics
• Fig. 56 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Sweden Country Dynamics
• Fig. 58 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Norway Country Dynamics
• Fig. 60 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 China Country Dynamics
• Fig. 63 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Japan Country Dynamics
• Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 India Country Dynamics
• Fig. 67 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Thailand Country Dynamics
• Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 South Korea Country Dynamics
• Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Australia Country Dynamics
• Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Brazil Country Dynamics
• Fig. 76 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Argentina Country Dynamics
• Fig. 78 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 80 South Africa Country Dynamics
• Fig. 81 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Saudi Arabia Country Dynamics
• Fig. 83 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 84 UAE Country Dynamics
• Fig. 85 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Kuwait Country Dynamics
• Fig. 87 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Market Position of Key Market Players

Self-amplifying RNA Synthesis Market Growth & Trends:

The global self-amplifying RNA synthesis market size is expected to reach USD 310.8 million by 2030 and is anticipated to grow at a CAGR of 19.24% from 2025 to 2030. This expansion is largely driven by the increasing demand for RNA-based vaccines and therapies, particularly during the COVID-19 pandemic. Researchers are turning to saRNA as a promising platform for rapid vaccine development due to its ability to induce a stronger immune response. The self-amplification feature of RNA allows for lower dosages and potentially fewer side effects, which is gaining traction in clinical trials. As a result, pharmaceutical companies are focusing on incorporating saRNA into their product pipelines, further boosting market growth.

The growing interest in personalized medicine is another key factor contributing to the market's expansion. With advancements in genomic technologies, there is an increasing need for tailored treatments targeting specific genetic profiles. Self-amplifying RNA technologies enable the development of vaccines and gene therapies that can be customized for individual patients. Furthermore, as healthcare systems shift toward more personalized care, the demand for innovative solutions such as saRNA will continue to rise.

In addition, the global rise in infectious diseases and the urgent need for new therapeutic options create a favorable environment for saRNA technologies. Beyond vaccines, self-amplifying RNA is being explored for various diseases, including cancer, genetic disorders, and autoimmune diseases. The ability of saRNA to be engineered for different applications allows for diverse therapeutic options, attracting substantial investment from the public and private sectors. Moreover, the ongoing advancements in RNA technology and the increasing number of clinical trials are expected to accelerate market adoption. This growing interest in multi-disease applications ensures a promising outlook for the global self-amplifying RNA synthesis market in the coming years.

Self-amplifying RNA Synthesis Market Report Highlights:

• Based on product & service, the custom synthesis services segment is expected to witness the fastest growth rate during the forecast period, due to the increasing demand for tailored RNA solutions, which are essential in the development of personalized medicines and RNA-based therapeutics.
• Based on an application, the therapeutics development segment dominated the market and accounted for the largest revenue share in 2024, driven by the surge in research and development of RNA-based therapeutics, such as vaccines and gene-editing tools, which have significantly contributed to the growth of this segment.
• Based on end use, the pharmaceutical & biotechnology companies segment held the largest revenue share in 2024. These companies are in charge of RNA therapeutic research, product development, and large-scale production, thus creating a substantial demand for RNA synthesis services. Their significant investments in RNA technology, particularly for vaccine production and genetic therapies, have positioned them as major players in the market. The growing number of RNA-based therapies in development, including novel vaccines and gene therapies, ensures that these companies remain the primary end-users of RNA synthesis solutions.
• Based on region, North America held the largest revenue share in 2024 in the self-amplifying RNA synthesis market, primarily driven by the region's strong pharmaceutical and biotechnology industries. The U.S. continues to lead RNA technology research, with significant investments in RNA-based therapeutics and vaccine development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Self-Amplifying RNA Synthesis Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Advancements in RNA Technology
    • 3.2.1.2. Rising Demand for Personalized Medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Manufacturing and Scalability Challenges
    • 3.2.2.2. Regulatory and Scientific Hurdles
• 3.3. Self-Amplifying RNA Synthesis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Self-Amplifying RNA Synthesis Market: Product & Service Estimates & Trend Analysis

• 4.1. Product & Service Segment Dashboard
• 4.2. Global Self-Amplifying RNA Synthesis Market Product & Service Movement Analysis
• 4.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.2. Premade saRNA
    • 4.4.2.1. Premade saRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.3. Enzymes & Reagents
    • 4.4.3.1. Enzymes & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Custom Synthesis Services
  • 4.5.1. Custom Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Self-Amplifying RNA Synthesis Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Self-Amplifying RNA Synthesis Market Application Movement Analysis
• 5.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Therapeutics Development
  • 5.4.1. Therapeutics Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.2. Infectious Diseases
    • 5.4.2.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.3. Oncology
    • 5.4.3.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Biomedical Research
  • 5.5.1. Biomedical Research Techniques Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Self-Amplifying RNA Synthesis Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Self-Amplifying RNA Synthesis Market End Use Movement Analysis
• 6.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.6. Other End Use
  • 6.6.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. Self-Amplifying RNA Synthesis Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Strategy Mapping
• 8.4. Participants Overview
  • 8.4.1. GenScript
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product & Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Creative Biogene
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product & Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. OZ Biosciences
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product & Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. BOC Sciences
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product & Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Croyez Bioscience Co., Ltd.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product & Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Creative Biolabs
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product & Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Maravai LifeSciences
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product & Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Areterna LLC
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product & Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Applied DNA Sciences, Inc. (LineaRx)
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product & Service benchmarking
    • 8.4.9.4. Strategic initiatives